The translational regulator dFMRP interacts with epidermal growth factor receptor to regulate apoptosis in Drosophila

dc.contributor.authorZic, Jessica Z.
dc.contributor.authorSherwood, Jacqueline E.
dc.contributor.authorTessier, Charles R.
dc.date.accessioned2016-08-02T18:18:28Z
dc.date.available2016-08-02T18:18:28Z
dc.date.issued2016-04-08
dc.descriptionposter abstracten_US
dc.description.abstractPosttranscriptional gene regulation is required for all aspects of cellular and tissue development and is a major mechanism underlying many diseases ranging from neurological disorders to cancer. The translational repressor fragile x mental retardation protein (FMRP) is ubiquitously expressed throughout development but is silenced in Fragile X Syndrome, an autism spectrum disorder. Interestingly, high levels of FMRP have recently been identified in human metastatic breast cancer. FMRP overexpression in these patients is directly correlated with increased lung metastasis suggesting a direct role for translational regulation both in cell proliferation and in invasive cell migration. Interestingly, however, FMRP can promote both proliferation and apoptosis. To dissect FMRP’s role in cancer development and progression, we are exploiting the powerful genetic system of Drosophila. Drosophila is an excellent model organism for human diseases associated with FMRP due to the strong evolutionary conservation of the fragile x mental retardation gene 1 which encodes this protein. dFMRP was overexpressed in the Drosophila imaginal wing disc, an epithelial tissue model. Contrary to a role in proliferation, overexpression of dFMRP leads to obvious cell loss in the adult wing and an increase in apoptotic markers. Using a combinatorial genetic screen, we have identified genes which are able to suppress this apoptotic phenotype and thus may be important for FMRP-­‐dependent tumorigenesis. Our focus is now on the epidermal growth factor receptor (EGFR) signaling pathway since blocking this mechanism is able to completely rescue the dFMRP-­‐overexpression wing defects. Clonal analysis reveals that dFMRP overexpressing cells survive their dFMRP-­induced apoptotic programming when co-­‐expressing a dominant negative form of EGFR. Additional clonal analyses are being used to explore the potential significance of this survival on tumor formation and metastasis.en_US
dc.identifier.citationJessica Z. Zic, Jacqueline E. Sherwood, and Charles R. Tessier. 2016, April 8. The translational regulator dFMRP interacts with epidermal growth factor receptor to regulate apoptosis in Drosophila. Poster session presented at IUPUI Research Day 2016, Indianapolis, Indiana.en_US
dc.identifier.urihttps://hdl.handle.net/1805/10551
dc.language.isoen_USen_US
dc.publisherOffice of the Vice Chancellor for Researchen_US
dc.subjectPosttranscriptional gene regulationen_US
dc.subjecttissue developmenten_US
dc.subjectcellular developmenten_US
dc.subjectfragile x mental retardation protein (FMRP)en_US
dc.subjectFragile X Syndromeen_US
dc.subjectautism spectrum disorderen_US
dc.subjectDrosophilaen_US
dc.titleThe translational regulator dFMRP interacts with epidermal growth factor receptor to regulate apoptosis in Drosophilaen_US
dc.typePosteren_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Zic.pdf
Size:
49.3 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.88 KB
Format:
Item-specific license agreed upon to submission
Description: